Wells Fargo Maintains Overweight on Alkermes, Raises Price Target to $43

Alkermes Public Limited Company -1.92%

Alkermes Public Limited Company

ALKS

33.22

-1.92%

Wells Fargo analyst Benjamin Burnett maintains Alkermes (NASDAQ: ALKS) with a Overweight and raises the price target from $37 to $43.